La maladie de Parkinson en France (serveur d'exploration) - Checkpoint (PascalFrancis)

Index « Keywords » - entrée « Pharmacokinetics »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Pharmacokinetic pharmacodynamic relationship < Pharmacokinetics < Pharmacologic test  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 26.
[0-20] [0 - 20][0 - 26][20-25][20-40]
Ident.Authors (with country if any)Title
000B27 (2005) Nicolas Simon [France] ; Joëlle Micallef [France] ; Jean-Charles Reynier [France] ; Monique Lesourd [France] ; Tatiana Witjas [France] ; André Alicherif [France] ; Jean-Philippe Azulay [France] ; Olivier Blin [France]End-of-dose akinesia after a single intravenous infusion of the dopaminergic agonist piribedil in Parkinson's disease patients : A pharmacokinetic/pharmacodynamic, randomized, double-blind study
000B38 (2005) Frédéric Libert [France] ; Francois Coudore [France] ; Damien Richard [France] ; Franck Durif [France] ; Alain Eschalier [France]Development of a gas chromatographic/mass spectrometric method to quantify R(-)-apomorphine, R(-)-apocodeine and R(-)-norapomorphine in human plasma and urine
000C13 (2004) Jan C. M. Zijlmans [Royaume-Uni, Pays-Bas] ; Berengere Debilly [France] ; Olivier Rascol [France] ; Andrew J. Lees [Royaume-Uni] ; Franck Durif [France]Safety of entacapone and apomorphine coadministration in levodopa-treated Parkinson's disease patients: Pharmacokinetic and pharmacodynamic results of a multicenter, double-blind, placebo-controlled, cross-over study
000D73 (2003) Asteria Luzardo-Alvarez [Espagne] ; M. Begona Delgado-Charro [France] ; José Blanco-Mendez [Espagne]In vivo lontophoretic administration of ropinirole hydrochloride
000D84 (2003) Charles Crevoisier [Suisse] ; Patricia Zerr [France] ; Francoise Calvi-Gries [France] ; Turid Nilsen [Norvège]Effects of food on the pharmacokinetics of levodopa in a dual-release formulation
000D95 (2003) C. Crevoisier [Suisse] ; A. Monreal [France] ; B. Metzger [France] ; T. Nilsen [Norvège]Comparative single- and multiple-dose pharmacokinetics of levodopa and 3-O-methyldopa following a new dual-release and a conventional slow-release formulation of levodopa and benserazide in healthy volunteers
000E32 (2002) J. L. Montastruc [France] ; O. Rascol [France]Propriétés pharmacodynamiques des agonistes dopaminergiques ? Quelle transférabilité en pratique clinique dans le traitement de la maladie de Parkinson ?
000F30 (2002) H. E. Junginger [Pays-Bas]Iontophoretic delivery of apomorphine: from in-vitro modelling to the Parkinson patient
000F34 (2002) A. Angles [France] ; H. Bagheri [France] ; S. Saivin [France] ; J. L. Montastruc [France]Interaction between lansoprazole and bromocriptine in a patient with Parkinson's disease
000F66 (2002) Bernard Bruguerolle [France] ; Nicolas Simon [France]Biologic rhythms and Parkinson's disease: A chronopharmacologic approach to considering fluctuations in function
001172 (2000) L. A. Smith [Royaume-Uni] ; M. G. Jackson [Royaume-Uni] ; C. Bonhomme [France] ; C. Chezaubernard [France] ; K. B. Pearce [Royaume-Uni] ; P. Jenner [Royaume-Uni]Transdermal administration of piribedil reverses MPTP-induced motor deficits in the common marmoset
001190 (2000) Patrice Mayer [France] ; Pascale Brunel [France] ; Céline Chaplain [France] ; Christel Piedecoq [France] ; Francis Calmel [France] ; Philippe Schambel [France] ; Philippe Chopin [France] ; Thierry Wurch [France] ; Petrus J. Pauwels [France] ; Marc Marien [France] ; Jean-Louis Vidaluc [France] ; Thierry Imbert [France]New substituted 1-(2,3-dihydrobenzo[1,4]dioxin-2-ylmethyl)piperidin-4-yl derivatives with α2-Adrenoceptor antagonist activity
001209 (2000) Frédéric Dolle [France] ; Michel Bottlaender [France] ; Stéphane Demphel [France] ; Patrick Emond [France] ; Chantal Fuseau [France] ; Christine Coulon [France] ; Michele Ottaviani [France] ; Héric Valette [France] ; Christian Loc'H [France] ; Christer Halldin [Suède] ; Laurent Mauclaire [France] ; Denis Guilloteau [France] ; Bernard Maziere [France] ; Christian Crouzel [France]Highly efficient synthesis of [11C]PE2I, a selective radioligand for the quantification of the dopamine transporter using PET
001329 (1999) C. Thalamas [France] ; A. Taylor [Royaume-Uni] ; C. Brefel-Courbon [France] ; S. Eagle [Royaume-Uni] ; K. Fitzpatrick [Royaume-Uni] ; O. Rascol [France]Lack of pharmacokinetic interaction between ropinirole and theophylline in patients with Parkinson's disease
001336 (1999) H. Valette [France] ; M. Bottlaender [France] ; F. Dolle [France] ; I. Guenther [France] ; C. Fuseau [France] ; C. Coulon [France] ; M. Ottaviani [France] ; C. Crouzel [France]Imaging central nicotinic acetylcholine receptors in baboons with [18F]fluoro-A-85380
001377 (1998-04) Synthèse de radioligands marqués au brome-76 et au carbone-11 pour l'étude des récepteurs N-Méthyl-D-Aspartate par Tomographie d'Emission de Positons
001454 (1998) C. Brefel [France] ; C. Thalamas [France] ; S. Rayet [France] ; A. Lopez-Gil [Royaume-Uni] ; K. Fitzpatrick [Royaume-Uni] ; S. Bullman [Royaume-Uni] ; D. R. Citerone [Royaume-Uni] ; A. C. Taylor [Royaume-Uni] ; J. L. Montastruc [France] ; O. Rascol [France]Effect of food on the pharmacokinetics of ropinirole in parkinsonian patients
001502 (1997) P. Pollak [France]Mécanismes et traitements de la maladie de Parkinson : Mouvements anormaux
001537 (1997) A. Daniele [Italie] ; A. Albanese [France] ; G. Gainotti [France] ; B. Gregori [France] ; P. Bartolomeo [France]Zolpidem in Parkinson's disease
001790 (1994) J. Dow [France] ; F. Piriou ; E. Wolf [France] ; B. D. Dulery [France] ; K. D. HaegeleNovel carbamate metabolites of mofegiline, a primary amine monoamine oxidase B inhibitor, in dogs and humans
001867 (1993) F. Durif [France] ; M. Paire [France] ; D. Deffond [France] ; A. Eschalier [France] ; G. Dordain [France] ; M. Tournilhac [France] ; J. Lavarenne [France]Relation between clinical efficacy and pharmacokinetic parameters after sublingual apomorphine in Parkinson's disease

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PascalFrancis/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/KwdEn.i -k "Pharmacokinetics" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/KwdEn.i  \
                -Sk "Pharmacokinetics" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PascalFrancis
   |étape=   Checkpoint
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Pharmacokinetics
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024